[Warning] 95% of Americans On This Drug Don’t Need It
It starts innocently.
A little nerve pain. A bad back. Trouble sleeping.
You go to your doctor expecting a solution, and walk out with a prescription that isn’t an opioid.
That sounds like a win…right?
Not so fast. Because the drug many doctors turned to as the “safe alternative” is now raising serious red flags.
According to new research, up to 95% of people taking it don’t need it.
Even worse?
This drug you don’t need – and should never have been prescribed — could be destroying your memory.
And it can land you in the hospital… a nursing home… or worse.
When concerns about opioids exploded, physicians needed a backup plan.
Enter gabapentin.
Originally approved for seizures and a specific type of nerve pain, it quickly became a go-to for everything:
Back pain, arthritis, anxiety, insomnia, fibromyalgia, even alcohol withdrawal.
But here’s the problem…Almost all of those uses are off-label.
In fact, one large analysis found 95% of gabapentin prescriptions are for conditions it was never officially approved to treat.
That means millions of Americans are essentially part of a massive, uncontrolled experiment.
Now, the risks are coming into focus—and they’re not minor.
Doctors once believed gabapentin was harmless.
But newer data suggests otherwise:
- Breathing suppression — especially dangerous when combined with other medications
- Dependence and misuse — yes, even without being labeled a “controlled” drug in many states
- Cognitive decline — particularly in older adults
And here’s the most alarming finding: A large medical records study found that people taking gabapentin for chronic pain had:
- 29% higher risk of dementia
- 85% higher risk of mild cognitive impairment
That’s not a small signal. That’s a flashing warning light.
If you’re over 65, this matters even more.
Because gabapentin doesn’t just affect pain, it acts directly on the brain and nervous system.
That can lead to brain fog, memory lapses, slower reaction time, and increased fall risk.
And when combined with other common medications—like sleep aids or anti-anxiety drugs—the effects can compound quickly.
In some cases, researchers have linked these combinations to dangerous breathing problems during sleep.
This isn’t just about one drug. It’s about a pattern.
A drug gets labeled “safe,” prescriptions skyrocket, off-label use becomes the norm, then years later, the real risks finally surface.
By then? Millions have already been exposed.
If you—or someone you love—is taking gabapentin, don’t panic.
But don’t ignore this either. Ask your doctor:
- Why was this prescribed?
- Is it truly necessary for my condition?
- Are there safer alternatives?
And most importantly:
Never stop it abruptly—this drug can cause withdrawal symptoms if discontinued too quickly.
When 95% of prescriptions fall outside approved use…
You have to ask: Is this really medicine? Or is it guesswork on a massive scale?
And when your brain—and your memory—are on the line, that’s a risk worth questioning.
To staying sharp,
Ray Thatcher
Research Director, Health Sciences Institute
Sources:
- Peckham, A. M., Evoy, K. E., Ochs, L., & Covvey, J. R. (2018). Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?. Substance abuse : research and treatment, 12, 1178221818801311. https://doi.org/10.1177/1178221818801311
- Nguyen, T. D., Chua, K., Jiao, A., Bicket, M. C., Bohnert, A., & Lagisetty, P. (2026). US trends in long-term opioid therapy. JAMA. Advance online publication. https://doi.org/10.1001/jama.2026.3241
- Hahn, J., Jo, Y., Yoo, S. H., Shin, J., Yu, Y. M., & Ah, Y.-M. (2022). Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 1009950. https://doi.org/10.3389/fphar.2022.1009950
- Gomes, T., Juurlink, D. N., Antoniou, T., Mamdani, M. M., Paterson, J. M., & van den Brink, W. (2017). Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study. PLOS Medicine, 14(10), e1002396. https://doi.org/10.1371/journal.pmed.1002396
- Balakumar, P., & Chan, A. (2025, July 17). Risk of dementia increased with gabapentin prescription in back pain patients. 2 Minute Medicine. https://www.2minutemedicine.com/risk-of-dementia-increased-with-gabapentin-prescription-in-back-pain-patients/


